Your browser doesn't support javascript.
loading
Cytoreductive surgery followed by chemotherapy and olaparib maintenance in BRCA 1/2 mutated recurrent ovarian cancer: a retrospective MITO group study.
Cecere, Sabrina Chiara; Musacchio, Lucia; Bartoletti, Michele; Salutari, Vanda; Arenare, Laura; Lorusso, Domenica; Ronzino, Graziana; Lauria, Rossella; Cormio, Gennaro; Naglieri, Emanuele; Scollo, Paolo; Marchetti, Claudia; Raspagliesi, Francesco; Greggi, Stefano; Cinieri, Saverio; Bergamini, Alice; Orditura, Michele; Valabrega, Giorgio; Scambia, Giovanni; Martinelli, Fabio; De Matteis, Elisabetta; Cardalesi, Cinzia; Loizzi, Vera; Perniola, Giorgia; Carella, Claudia; Scandurra, Giuseppa; Giannone, Gaia; Pignata, Sandro.
Afiliación
  • Cecere SC; Department of Urology and Gynecology, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Naples, Italy.
  • Musacchio L; Department of Women and Child Health, Division of Gynecologic Oncology, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome, Italy.
  • Bartoletti M; Department of Maternal and Child Health and Urological Sciences, Policlinico Umberto I, Sapienza, University of Rome, Rome, Italy.
  • Salutari V; Unit of Medical Oncology and Cancer Prevention, Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano, CRO, Aviano, Italy.
  • Arenare L; Department of Medicine, University of Udine, Udine, Italy.
  • Lorusso D; Department of Women and Child Health, Division of Gynecologic Oncology, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome, Italy.
  • Ronzino G; Clinical Trial Unit, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Campania, Italy.
  • Lauria R; Department of Women and Child Health, Division of Gynecologic Oncology, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome, Italy.
  • Cormio G; Department of Life Science and Public Health, Catholic University of Sacred Heart, Largo Agostino Gemelli, Rome, Italy.
  • Naglieri E; Gynecologic Oncology Unit, Fondazione Istituto Nazionale Tumori IRCCS, Milan, Italy.
  • Scollo P; Medical Oncology Unit, Vito Fazzi Hospital, Lecce, Italy.
  • Marchetti C; Division of Medical Oncology, Azienda Ospedaliera Universitaria Federico II, Napoli, Campania, Italy.
  • Raspagliesi F; Gynecologic Oncology Unit, Department of Biomedical Sciences and Human Oncology, University of Bari, Bari, Italy.
  • Greggi S; Medical Oncology Unit, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
  • Cinieri S; Medical Oncology Unit, Cannizzaro Hospital, Catania, Italy.
  • Bergamini A; Department of Women and Child Health, Division of Gynecologic Oncology, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome, Italy.
  • Orditura M; Gynecologic Oncology Unit, Fondazione Istituto Nazionale Tumori IRCCS, Milan, Italy.
  • Valabrega G; Gynecologic Oncology, National Cancer Institute, Institute for Hospitalization and Care Scientific Foundation Pascale, Napoli, Campania, Italy.
  • Scambia G; Division of Medical Oncology, Ospedale "Senatore Antonio Perrino", Brindisi, Brindisi, Italy.
  • Martinelli F; Department of Obstetrics and Gynecology, IRCCS, San Raffaele Hospital, Milan, Italy.
  • De Matteis E; Università Vita Salute San Raffaele, Milan, Italy.
  • Cardalesi C; Università degli Studi della Campania Luigi Vanvitelli, Napoli, Campania, Italy.
  • Loizzi V; Candiolo Cancer Institute, FPO- IRCCS, Candiolo (TO), Italy.
  • Perniola G; Department of Oncology, University of Turin, Torino, Piemonte, Italy.
  • Carella C; Department of Women and Child Health, Division of Gynecologic Oncology, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome, Italy.
  • Scandurra G; Department of Life Science and Public Health, Catholic University of Sacred Heart, Largo Agostino Gemelli, Rome, Italy.
  • Giannone G; Gynecologic Oncology Unit, Fondazione Istituto Nazionale Tumori IRCCS, Milan, Italy.
  • Pignata S; Medical Oncology Unit, Vito Fazzi Hospital, Lecce, Italy.
Int J Gynecol Cancer ; 31(7): 1031-1036, 2021 07.
Article en En | MEDLINE | ID: mdl-33990353
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Ftalazinas / Piperazinas / Proteína BRCA1 / Proteína BRCA2 / Procedimientos Quirúrgicos de Citorreducción / Inhibidores de Poli(ADP-Ribosa) Polimerasas / Carcinoma Epitelial de Ovario / Recurrencia Local de Neoplasia Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Female / Humans / Middle aged Idioma: En Revista: Int J Gynecol Cancer Asunto de la revista: GINECOLOGIA / NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Italia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Ftalazinas / Piperazinas / Proteína BRCA1 / Proteína BRCA2 / Procedimientos Quirúrgicos de Citorreducción / Inhibidores de Poli(ADP-Ribosa) Polimerasas / Carcinoma Epitelial de Ovario / Recurrencia Local de Neoplasia Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Female / Humans / Middle aged Idioma: En Revista: Int J Gynecol Cancer Asunto de la revista: GINECOLOGIA / NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Italia